| Name | Title | Contact Details |
|---|
West Virginia Primary Care Association is a Charleston, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
As one of the largest and fastest-growing Emergency and Hospital Medicine groups in the nation, we partner with more than 5,000 world-class providers who treat more than 6 million patients annually. Physician-led, our team consists of motivated, personable, highly qualified people interested in putting the patient first. We’re committed to doing the right thing for the patients, physicians, and hospitals we serve. Which is why 98% of our physicians recommend us to colleagues and friends. William C. Schumacher, M.D., a board certified emergency medicine physician, formally founded the Schumacher Group in 1994. The philosophy behind Schumacher Group`s founding was based on his belief that there was a better way to deliver and manage emergency medical services in the hospital environment. That `better way` is embodied in our founding mission. The Schumacher Group became known as Schumacher Clinical Partners in 2016.
The CDM Group is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. The CDM Group is based in New York, NY. You can find more information on The CDM Group at www.thecdmgroup.com
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Elizabeth Township Medical Services is a Elizabeth, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.